Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
ArQule Ends Drug Trial
MarketMinute.com Stock News
Posted on October 02, 2012 at 13:40 PM EDT
ArQule Inc. (
) ended a Phase 3 MARQUEE clinical trial for failing to increase overall survival. Shares of the biotechnology company plummeted $2.70 to $2.29.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here